Im Kampf gegen Ebola bekommt die DR Kongo 70.000 Dosen des Impfstoffs Ervebo. Unklar ist, ob er gegen die vorherrschende Bundibugyo-Virusvariante wirkt. Eine klinische Studie soll das klären.

WHO experts say early evidence, including animal studies, suggests Ervebo could offer some protection—and the new trial will seek to establish whether that protection extends to…

The Democratic Republic of Congo has been allocated 70,000 doses of Merck’s Ervebo vaccine for Ebola, the World Health Organization said on Thursday, as the country attempts to…